Table S2.
Potential inappropriate medicines that resulted in ADRs among study participants
| PIM in Nigeria | n (%) | PIM in South Africa | n (%) |
|---|---|---|---|
|
| |||
| Diclofenac | 3 (20.0) | Ibuprofen | 2 (20.0) |
| Tramadol | 1 (6.7) | Tramadol | 2 (20.0) |
| Pentazocine | 2 (13.3) | Insulin sliding scale | 4 (10.0) |
| Steroid + Tramadol + Aspirin (>325 mg) | 1 (6.7) | Prazosin | 1 (10.0) |
| Amitryptiline | 2 (13.3) | Lorazepam | 1 (10.0) |
| Chlorpromazine | 2 (13.3) | – | – |
| Methyldopa (antihypertensive) | 2 (13.3) | – | – |
| Digoxin | 1 (6.7) | – | – |
| Bromazepam | 1 (6.7) | – | – |
| Total | 15 (100.0) | Total | 10 (100.0) |
Abbreviations: ADRs, adverse drug reactions; PIM, potentially inappropriate medicine.